195 related articles for article (PubMed ID: 22849427)
1. Neurometabolite effects of response to quetiapine and placebo in adolescents with bipolar depression.
Chang K; Delbello M; Chu WJ; Garrett A; Kelley R; Mills N; Howe M; Bryan H; Adler C; Eliassen J; Spielman D; Strakowski SM
J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):261-8. PubMed ID: 22849427
[TBL] [Abstract][Full Text] [Related]
2. Neurofunctional Correlates of Response to Quetiapine in Adolescents with Bipolar Depression.
Chang K; DelBello M; Garrett A; Kelley R; Howe M; Adler C; Welge J; Strakowski SM; Singh M
J Child Adolesc Psychopharmacol; 2018; 28(6):379-386. PubMed ID: 29847157
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical effects of quetiapine in patients with bipolar mania: a proton magnetic resonance spectroscopy study.
Adler CM; DelBello MP; Weber WA; Jarvis KB; Welge J; Chu WJ; Rummelhoff E; Kim MJ; Lee JH; Strakowski SM
J Clin Psychopharmacol; 2013 Aug; 33(4):528-32. PubMed ID: 23764689
[TBL] [Abstract][Full Text] [Related]
4. Neurochemical alterations in adolescent bipolar depression: a proton magnetic resonance spectroscopy pilot study of the prefrontal cortex.
Patel NC; Cecil KM; Strakowski SM; Adler CM; DelBello MP
J Child Adolesc Psychopharmacol; 2008 Dec; 18(6):623-7. PubMed ID: 19108667
[TBL] [Abstract][Full Text] [Related]
5. Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial.
McNamara RK; Strawn JR; Tallman MJ; Welge JA; Patino LR; Blom TJ; DelBello MP
J Child Adolesc Psychopharmacol; 2020 Jun; 30(5):293-305. PubMed ID: 32167792
[No Abstract] [Full Text] [Related]
6. Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study.
DelBello MP; Cecil KM; Adler CM; Daniels JP; Strakowski SM
Neuropsychopharmacology; 2006 Jun; 31(6):1264-73. PubMed ID: 16292323
[TBL] [Abstract][Full Text] [Related]
7. Cortical neurochemistry in euthymic patients with bipolar I disorder.
Scherk H; Backens M; Schneider-Axmann T; Usher J; Kemmer C; Reith W; Falkai P; Gruber O
World J Biol Psychiatry; 2009; 10(4):285-94. PubMed ID: 19921970
[TBL] [Abstract][Full Text] [Related]
8. Differential neurometabolite alterations in brains of medication-free individuals with bipolar disorder and those with unipolar depression: a two-dimensional proton magnetic resonance spectroscopy study.
Li H; Xu H; Zhang Y; Guan J; Zhang J; Xu C; Shen Z; Xiao B; Liang C; Chen K; Zhang J; Wu R
Bipolar Disord; 2016 Nov; 18(7):583-590. PubMed ID: 27870506
[TBL] [Abstract][Full Text] [Related]
9. Lithium-associated anterior cingulate neurometabolic profile in euthymic Bipolar I disorder: A
Soeiro-de-Souza MG; Otaduy MCG; Machado-Vieira R; Moreno RA; Nery FG; Leite C; Lafer B
J Affect Disord; 2018 Dec; 241():192-199. PubMed ID: 30130684
[TBL] [Abstract][Full Text] [Related]
10. Anterior cingulate cortex and cerebellar hemisphere neurometabolite changes in depression treatment: A 1H magnetic resonance spectroscopy study.
Chen LP; Dai HY; Dai ZZ; Xu CT; Wu RH
Psychiatry Clin Neurosci; 2014 May; 68(5):357-64. PubMed ID: 24393367
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine: a review of its use in the management of bipolar depression.
Sanford M; Keating GM
CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
[TBL] [Abstract][Full Text] [Related]
13. (1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.
Howells FM; Uhlmann A; Temmingh H; Sinclair H; Meintjes E; Wilson D; Stein DJ
Schizophr Res; 2014 Mar; 153(1-3):122-8. PubMed ID: 24529366
[TBL] [Abstract][Full Text] [Related]
14. Differential hemodynamic brain activity in schizophrenia patients with blunted affect during quetiapine treatment.
Fahim C; Stip E; Mancini-Marïe A; Gendron A; Mensour B; Beauregard M
J Clin Psychopharmacol; 2005 Aug; 25(4):367-71. PubMed ID: 16012281
[TBL] [Abstract][Full Text] [Related]
15. Lithium treatment effects on Myo-inositol in adolescents with bipolar depression.
Patel NC; DelBello MP; Cecil KM; Adler CM; Bryan HS; Stanford KE; Strakowski SM
Biol Psychiatry; 2006 Nov; 60(9):998-1004. PubMed ID: 17056394
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
[TBL] [Abstract][Full Text] [Related]
17. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder.
Davanzo P; Thomas MA; Yue K; Oshiro T; Belin T; Strober M; McCracken J
Neuropsychopharmacology; 2001 Apr; 24(4):359-69. PubMed ID: 11182531
[TBL] [Abstract][Full Text] [Related]
18. A proton magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in acute mania.
Frey BN; Folgierini M; Nicoletti M; Machado-Vieira R; Stanley JA; Soares JC; Kapczinski F
Hum Psychopharmacol; 2005 Mar; 20(2):133-9. PubMed ID: 15648094
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents.
Davanzo P; Yue K; Thomas MA; Belin T; Mintz J; Venkatraman TN; Santoro E; Barnett S; McCracken J
Am J Psychiatry; 2003 Aug; 160(8):1442-52. PubMed ID: 12900307
[TBL] [Abstract][Full Text] [Related]
20. Anterior cingulate cortex neuro-metabolic changes underlying lithium-induced euthymia in bipolar depression: A longitudinal
Soeiro-de-Souza MG; Scotti-Muzzi E; Fernandes F; De Sousa RT; Leite CC; Otaduy MC; Machado-Vieira R
Eur Neuropsychopharmacol; 2021 Aug; 49():93-100. PubMed ID: 33882433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
